Exploring GLP-1 Agonists in Neurodegenerative Treatment

This chapter examines the potential of GLP-1 receptor agonists for treating neurodegenerative diseases like Parkinson's and Alzheimer's. It highlights current research, genetic insights, and the need for comprehensive clinical trials to advance effective therapeutic strategies.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app